Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on chronic GVHD.
Rodriguez
R
R
Nademanee
A
A
Palmer
J M
JM
Parker
P
P
Nakamura
R
R
Snyder
D
D
Pullarkat
V
V
Zain
J
J
Smith
E
E
Sahebi
F
F
Patane
K
K
Senitzer
D
D
Chang
K
K
Forman
S J
SJ
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000961:Antilymphocyte Serum; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D006086:Graft vs Host Disease / Q000517:prevention & control*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D016572:Cyclosporine; C512542:thymoglobulin; D009173:Mycophenolic Acid